SIA "Takeda Latvia"Active

40003799209Limited liability companyFounded 2006

Key figures

1 181 010 €+9,1%
Revenue 2025
-2,1%
Average annual change 2008–2025
01 m2 m3 m’08’09’10’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
0500 k1 m1,5 m’08’09’10’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Dividends

calculated
2025

No dividends were paid.

History
20250 €
20240 €
20230 €
20220 €
20210 €
20200 €
20190 €
20180 €
20170 €
2016 ~110 881 €
20150 €
20140 €
20130 €
20120 €
20110 €
20100 €
20090 €
20080 €
Summary of financial statements2008–2025
200820092010201120122013201420152016201720182019202020212022202320242025
Balance sheet — assets
Total current assets431 248455 242597 762712 680920 520971 988606 374626 204566 990731 405649 018850 020885 445888 030975 0031 001 942974 4521 009 859
Total non-current assets28 22331 92930 86226 76132 83742 89425 62325 70825 25167356596368934 71727 38214 08651 85182 189103 295
Total assets459 471487 171628 624739 441953 3571 014 882631 997651 912592 241738 140655 614853 709920 162915 412989 0891 053 7931 056 6411 113 154
Balance sheet — liabilities and equity
Current liabilities107 49652 10891 486137 028269 489000220 522310 214162 366285 903305 002227 861279 724280 252245 604290 152
Non-current liabilities12650000429 223203 100242 9000000000000
Total liabilities108 76152 10891 486137 028269 489429 223203 100242 900220 522310 214162 366285 903305 002227 861279 724280 252245 604290 152
Share capital——————————————————
Retained earnings of previous periods——————————————————
Profit for the year107 14984 353102 07565 27566 825110 88193 22188 23573 58856 20765 32274 55847 35472 39121 81464 17637 49611 966
Total equity350 710435 063537 138602 413678 400573 794428 897409 012371 719427 926493 248567 806615 160687 551709 365773 541811 037823 002
Income statement
Sales revenue1 695 3611 489 0781 599 8421 447 8831 712 4712 782 4322 317 3532 205 3901 817 9091 523 9721 371 0441 464 4511 183 8891 203 4141 083 2331 100 6411 082 8331 181 010
Operating profit130 56799 197119 56075 00879 365131 345110 355104 96986 58872 57065 32274 75246 58672 38925 87057 48240 85863 251
Profit before income tax130 77899 321119 61577 30979 435131 375110 446104 96986 58872 57065 32274 55847 35472 39128 65378 88355 14770 210
Profit for the reporting year107 14984 353102 07565 27566 825110 88193 22188 23573 58856 20765 32274 55847 35472 39121 81464 17637 49611 966
Labour costs——————————————————
Depreciation of non-current assets——————————————————
Other indicators
Employees25252218181815148565567777
Calculated dividend00000000110 881000000000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
100%SIA "Takeda Latvia"Takeda Pharmaceutical…Leahy KieranPetrossian Devon Hash…Slomczynski Jacek Pio…
CompanyPersonShareholderOther roleAdditional link

Summary: SIA "Takeda Latvia"

Overview

SIA "Takeda Latvia" (reg. no. 40003799209) is a limited liability company. The company was registered in 2006 and has been in the register for 20 years. Registered address: Rīga, Skanstes iela 50.

Financial results

Revenue in 2025 was 1 181 010 €, up 9,1% on the previous year (1 082 833 €). From 2008 to 2025, revenue declined by an average of 2,1% per year. Net profit for 2025 was 11 966 € (1,0% of revenue). The company was profitable in all 18 published years. In 2025 the company had 7 employees. Revenue per employee was 168 716 €. At the end of 2025, total assets were 1 113 154 € and equity 823 002 € (73,9% of assets).

Management and owners

The board has 3 members. The sole owner of the company is Takeda Pharmaceuticals International AG.

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.